Accès gratuit
Med Sci (Paris)
Volume 21, Numéro 2, Février 2005
Page(s) 216 - 221
Section Forum
Publié en ligne 15 février 2005
  1. Bourre JM, François M, Youyou A, et al. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning task in rat. J Nutr 1989; 119 : 1880–92.
  2. Frances H, Drai P, Smirnova M, et al. Nutritional (n-3) polyunsaturated fatty acids influence the behavioral responses to positive events in mice. Neurosci Lett 2000; 285 : 223–7.
  3. Kodas E, Vancassel S, Lejeune B, et al. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats : critical role of developmental stage. J Lipid Res 2002; 43 : 1209–19.
  4. Carrie I, Guesnet P, Bourre JM, Frances H. Diets containing long-chain n-3 polyunsaturated fatty acids affect behaviour differently during development than ageing in mice. Br J Nutr 2000; 83 : 439–47.
  5. Bourre JM, Faivre A, Dumont O, et al. Effect of polyunsaturated fatty acids on fetal mouse brain cells in culture in a chemically defined medium. J Neurochem 1983; 41 : 1234–42.
  6. Bourre JM, Pascal G, Durand G, et al. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoided of (n-3) fatty acids. J Neurochem 1984; 43 : 342–8.
  7. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during aging. J Nutr Health Aging 2003; 8 : 163–74.
  8. Homayoun P, Durand G, Pascal G, Bourre JM. Alteration in fatty acid composition of adult rat brain capillaries and choroid plexus induced by a diet deficient in n-3 fatty acids : slow recovery after substitution with a nondeficient diet. J Neurochem 1988; 51 : 45–8.
  9. Ximenes DS, Lavialle F, Gendrot G, et al. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem 2002; 81 : 1328–37.
  10. Silvers KM, Scott KM. Fish consumption and self-reported physical and mental health status. Public Health Nutr 2002; 5 : 427–31.
  11. Ness AR, Gallacher JE, Bennett PD, et al. Advice to eat fish and mood : a randomised controlled trial in men with angina. Nutr Neurosci 2003; 6 : 63–5.
  12. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. Fatty acid mixture counters stress changes in cortisol, cholesterol, and impair learning. Int J Neurosci 2000; 101 : 73–87.
  13. Hamazaki T, Itomura M, Sawazaki S, Nagao Y. Anti-stress effects of DHA. Biofactors 2000; 13 : 41–5.
  14. Iribarren C, Markovitz JH, Jacobs DR, et al. Dietary intake of n-3, n-6 fatty acids and fish : relationship with hostility in young adults, the CARDIA study. Eur J Clin Nutr 2004; 58 : 24–31
  15. Hamazaki T, Thienprasert A, Kheovichai K, et al. The effect of docosahexaenoic acid on aggression in elderly Thai subjects : a placebo-controlled double-blind study. Nutr Neurosci 2002; 5 : 37–41.
  16. Buydens-Branchey L, Branchey M, McMakin DL, Hibbeln JR. Polyunsaturated fatty acid status and relapse vulnerability in cocaine addicts. Psychiatry Res 2003; 120 : 29–35.
  17. Richardson AJ, Calvin CM, Clisby C, et al. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot Essent Fatty Acids 2000; 63 : 69–74.
  18. Vancassel S, Durand G, Barthelemy C, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 2001; 65 : 1–7.
  19. Johnson SM, Hollander E. Evidence that eicosapentaenoic acid is effective in treating autism. J Clin Psychiatry 2003; 64 : 848–9.
  20. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2002; 67 : 311–8.
  21. Bates D. Racially determined abnormal essential fatty acid and prostaglandin metabolism and food allergies linked to autoimmune, inflammatory, and psychiatric disorders among coastal British Columbia indians. Med Hypotheses 1988; 25 : 103–9.
  22. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression : when cholesterol does not satisfy. Am J Clin Nutr 1995; 62 : 1–9.
  23. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 2001; 52 : 529–31.
  24. Hakkarainen R, Partonen T, Haukka J, et al. Is low dietary intake of omega-3 fatty acids associated with depression ? Am J Psychiatry 2004; 161 : 567–9.
  25. Hibbeln JR. Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression : a cross-national, ecological analysis. J Affect Disord 2002; 69 : 15–29.
  26. Chiu CC, Huang SY, Shen WW, Su KP. Omega-3 fatty acids for depression in pregnancy. Am J Psychiatry 2003; 160 : 385.
  27. Marangell LB, Martinez JM, Zboyan HA, et al. Omega-3 fatty acids for the prevention of postpartum depression : negative data from a preliminary, open-label pilot study. Depress Anxiety 2004; 19 : 20–3.
  28. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002; 59 : 913–9.
  29. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003; 160 : 996–8.
  30. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003; 13 : 267–71.
  31. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996; 31 : S157–61.
  32. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48 : 149–55.
  33. Tiemeier H, van Tuijl HR, Hofman A, et al. Plasma fatty acid composition and depression are associated in the elderly : the Rotterdam study. Am J Clin Nutr 2003; 78 : 40–6.
  34. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder : a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56 : 407–12.
  35. Noaghiul S, Hibbeln JR. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 2003; 160 : 2222–7.
  36. Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997; 42 : 776–82.
  37. Heude B, Ducimetiere P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes : The EVA Study. Am J Clin Nutr 2003; 77 : 803–8.
  38. Barberger-Gateau P, Letenneur L, Deschamps V, et al. Fish, meat, and risk of dementia : cohort study. Br Med J 2002; 325 : 932–3.
  39. Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 2003; 60 : 194–200.
  40. Otsuka M. Analysis of dietary factors in Alzheimer’s disease : clinical use of nutritional intervention for prevention and treatment of dementia. Nippon Ronen Igakkai Zasshi 2000; 37 : 970–3.
  41. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Diet and risk of dementia : does fat matter ? The Rotterdam study. Neurology 2002; 59 : 1915–21.
  42. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. Essential fatty acids preparation (SR-3) improves Alzheimer’s patients quality of life. Int J Neurosci 1996; 87 : 141–9.
  43. Horrobin DF. Schizophrenia : the illness that made us human. Med Hypotheses 1998; 50 : 269–88.
  44. Peet M, Laugharne JD, Mellor J, Ramchand CN. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot Essent Fatty Acids 1996; 55 : 71–5.
  45. Assies J, Lieverse R, Vreken P, et al. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 2001; 49 : 510–22.
  46. Puri BK, Richardson AJ, Horrobin DF, et al. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int J Clin Pract 2000; 54 : 57–63.
  47. Emsley R, Oosthuizen P, van Rensburg SJ. Clinical potential of omega-3 fatty acids in the treatment of schizophrenia. CNS Drugs 2003; 17 : 1081–91.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.